Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenon versus sevoflurane anesthesia for perioperative neurotoxicity biomarkers
ACTRN12618000916246Phase 4Completed
- Sponsor
- St Vincent's Hospital Melbourne
- Start
- Mar 2019
- Modality
- Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in None comparing Xenon anesthesia with Sevoflurane anesthesia (2 arms). Primary endpoints: Change in tau protein and Change in neurofilament light. Started Mar 2019; status: completed.
02
Drugs
xenonsevoflurane
Beyond the preview
Go deeper on ACTRN12618000916246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000916246.